1887

Journal of General Virology header logo

Volume 86, Issue 12

Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins Free

Abstract

Hepatitis C virus (HCV) E1 and E2 envelope glycoproteins (GPs) displayed on retroviral cores (HCVpp) are a powerful and highly versatile model system to investigate wild-type HCV entry. To further characterize this model system, the cellular site of HCVpp assembly and the respective roles of the HCV GPs in this process were investigated. By using a combination of biochemical methods with confocal and electron microscopic techniques, it was shown that, in cells producing HCVpp, both E1 and E2 colocalized with retroviral core proteins intracellularly, presumably in multivesicular bodies, but not at the cell surface. When E1 and E2 were expressed individually with retroviral core proteins, only E2 colocalized with and was incorporated on retroviral cores. Conversely, the colocalization of E1 with retroviral core proteins and its efficient incorporation occurred only upon co-expression of E2. Moreover, HCVpp infectivity correlated strictly with the presence of both E1 and E2 on retroviral cores. Altogether, these results confirm that the E1E2 heterodimer constitutes the prebudding form of functional HCV GPs and, more specifically, show that dimerization with E2 is a prerequisite for efficient E1 incorporation onto particles.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.81428-0
2005-12-01
2024-05-06
Loading full text...

Full text loading...

/deliver/fulltext/jgv/86/12/3189.html?itemId=/content/journal/jgv/10.1099/vir.0.81428-0&mimeType=html&fmt=ahah

References

  1. Alberts P., Galli T. 2003; The cell outgrowth secretory endosome (COSE): a specialized compartment involved in neuronal morphogenesis. Biol Cell 95:419–424 [CrossRef]
     [Google Scholar]
  2. André P., Perlemuter G., Budkowska A., Bréchot C., Lotteau V. 2005; Hepatitis C virus particles and lipoprotein metabolism. Semin Liver Dis 25:93–104 [CrossRef]
     [Google Scholar]
  3. Bartosch B., Bukh J., Meunier J.-C., Granier C., Engle R. E., Blackwelder W. C., Emerson S. U., Cosset F.-L., Purcell R. H. 2003a; In vitro assay for neutralizing antibody to hepatitis C virus: evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci U S A 100:14199–14204 [CrossRef]
     [Google Scholar]
  4. Bartosch B., Dubuisson J., Cosset F.-L. 2003b; Infectious hepatitis C virus pseudo-particles containing functional E1–E2 envelope protein complexes. J Exp Med 197:633–642 [CrossRef]
     [Google Scholar]
  5. Bartosch B., Vitelli A., Granier C. 7 other authors 2003c; Cell entry of hepatitis C virus requires a set of co-receptors that include the CD81 tetraspanin and the SR-B1 scavenger receptor. J Biol Chem 278:41624–41630 [CrossRef]
     [Google Scholar]
  6. Baumert T. F., Ito S., Wong D. T., Liang T. J. 1998; Hepatitis C virus structural proteins assemble into viruslike particles in insect cells. J Virol 72:3827–3836
     [Google Scholar]
  7. Blanchard E., Brand D., Trassard S., Goudeau A., Roingeard P. 2002; Hepatitis C virus-like particle morphogenesis. J Virol 76:4073–4079 [CrossRef]
     [Google Scholar]
  8. Blanchard E., Hourioux C., Brand D., Ait-Goughoulte M., Moreau A., Trassard S., Sizaret P.-Y., Dubois F., Roingeard P. 2003; Hepatitis C virus-like particle budding: role of the core protein and importance of its Asp111 . J Virol 77:10131–10138 [CrossRef]
     [Google Scholar]
  9. Buonocore L., Blight K. J., Rice C. M., Rose J. K. 2002; Characterization of vesicular stomatitis virus recombinants that express and incorporate high levels of hepatitis C virus glycoproteins. J Virol 76:6865–6872 [CrossRef]
     [Google Scholar]
  10. Cocquerel L., Meunier J.-C., Pillez A., Wychowski C., Dubuisson J. 1998; A retention signal necessary and sufficient for endoplasmic reticulum localization maps to the transmembrane domain of hepatitis C virus glycoprotein E2. J Virol 72:2183–2191
     [Google Scholar]
  11. Cocquerel L., Duvet S., Meunier J.-C., Pillez A., Cacan R., Wychowski C., Dubuisson J. 1999; The transmembrane domain of hepatitis C virus glycoprotein E1 is a signal for static retention in the endoplasmic reticulum. J Virol 73:2641–2649
     [Google Scholar]
  12. Cocquerel L., Wychowski C., Minner F., Penin F., Dubuisson J. 2000; Charged residues in the transmembrane domains of hepatitis C virus glycoproteins play a major role in the processing, subcellular localization, and assembly of these envelope proteins. J Virol 74:3623–3633 [CrossRef]
     [Google Scholar]
  13. Deleersnyder V., Pillez A., Wychowski C., Blight K., Xu J., Hahn Y. S., Rice C. M., Dubuisson J. 1997; Formation of native hepatitis C virus glycoprotein complexes. J Virol 71:697–704
     [Google Scholar]
  14. Drummer H. E., Maerz A., Poumbourios P. 2003; Cell surface expression of functional hepatitis C virus E1 and E2 glycoproteins. FEBS Lett 546:385–390 [CrossRef]
     [Google Scholar]
  15. Dubuisson J. 2000; Folding, assembly and subcellular localization of hepatitis C virus glycoproteins. Curr Top Microbiol Immunol 242:135–148
     [Google Scholar]
  16. Dubuisson J., Duvet S., Meunier J.-C., Op De Beeck A., Cacan R., Wychowski C., Cocquerel L. 2000; Glycosylation of the hepatitis C virus envelope protein E1 is dependent on the presence of a downstream sequence on the viral polyprotein. J Biol Chem 275:30605–30609 [CrossRef]
     [Google Scholar]
  17. Dubuisson J., Penin F., Moradpour D. 2002; Interaction of hepatitis C virus proteins with host cell membranes and lipids. Trends Cell Biol 12:517–523 [CrossRef]
     [Google Scholar]
  18. Dumonceaux J., Cormier E. G., Kajumo F., Donovan G. P., Roy-Chowdhury J., Fox I. J., Gardner J. P., Dragic T. 2003; Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1. J Virol 77:13418–13424 [CrossRef]
     [Google Scholar]
  19. Egger D., Wölk B., Gosert R., Bianchi L., Blum H. E., Moradpour D., Bienz K. 2002; Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex. J Virol 76:5974–5984 [CrossRef]
     [Google Scholar]
  20. Flint M., McKeating J. A. 1999; The C-terminal region of the hepatitis C virus E1 glycoprotein confers localization within the endoplasmic reticulum. J Gen Virol 80:1943–1947
     [Google Scholar]
  21. Flint M., Thomas J. M., Maidens C. M., Shotton C., Levy S., Barclay W. S., McKeating J. A. 1999; Functional analysis of cell surface-expressed hepatitis C virus E2 glycoprotein. J Virol 73:6782–6790
     [Google Scholar]
  22. Galli T., Chilcote T., Mundigl O., Binz T., Niemann H., De Camilli P. 1994; Tetanus toxin-mediated cleavage of cellubrevin impairs exocytosis of transferrin receptor-containing vesicles in CHO cells. J Cell Biol 125:1015–1024 [CrossRef]
     [Google Scholar]
  23. Gay B., Tournier J., Chazal N., Carrière C., Boulanger P. 1998; Morphopoietic determinants of HIV-1 Gag particles assembled in baculovirus-infected cells. Virology 247:160–169 [CrossRef]
     [Google Scholar]
  24. Gosert R., Egger D., Lohmann V., Bartenschlager R., Blum H. E., Bienz K., Moradpour D. 2003; Identification of the hepatitis C virus RNA replication complex in Huh-7 cells harboring subgenomic replicons. J Virol 77:5487–5492 [CrossRef]
     [Google Scholar]
  25. Gould S. J., Booth A. M., Hildreth J. E. K. 2003; The Trojan exosome hypothesis. Proc Natl Acad Sci U S A 100:10592–10597 [CrossRef]
     [Google Scholar]
  26. Greive S. J., Webb R. I., Mackenzie J. M., Gowans E. J. 2002; Expression of the hepatitis C virus structural proteins in mammalian cells induces morphology similar to that in natural infection. J Viral Hepat 9:9–17 [CrossRef]
     [Google Scholar]
  27. Guibinga G. H., Hall F. L., Gordon E. M., Ruoslahti E., Friedmann T. 2004; Ligand-modified vesicular stomatitis virus glycoprotein displays a temperature-sensitive intracellular trafficking and virus assembly phenotype. Mol Ther 9:76–84
     [Google Scholar]
  28. Hsu M., Zhang J., Flint M., Logvinoff C., Cheng-Mayer C., Rice C. M., McKeating J. A. 2003; Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles. Proc Natl Acad Sci U S A 100:7271–7276 [CrossRef]
     [Google Scholar]
  29. Kaito M., Watanabe S., Tsukiyama-Kohara K. 7 other authors 1994; Hepatitis C virus particle detected by immunoelectron microscopic study. J Gen Virol 75:1755–1760 [CrossRef]
     [Google Scholar]
  30. Lagging L. M., Meyer K., Owens R. J., Ray R. 1998; Functional role of hepatitis C virus chimeric glycoproteins in the infectivity of pseudotyped virus. J Virol 72:3539–3546
     [Google Scholar]
  31. Lindenbach B. D., Rice C. M. 2001; Flaviviridae : the viruses and their replication. In Fields Virology , 4th edn. pp  991–1041 Edited by Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott Williams & Wilkins;
     [Google Scholar]
  32. Lindenbach B. D., Evans M. J., Syder A. J. 8 other authors 2005; Complete replication of hepatitis C virus in cell culture. Science 309:623–626 [CrossRef]
     [Google Scholar]
  33. Logvinoff C., Major M. E., Oldach D. 7 other authors 2004; Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proc Natl Acad Sci U S A 101:10149–10154 [CrossRef]
     [Google Scholar]
  34. Mackenzie J. M., Westaway E. G. 2001; Assembly and maturation of the flavivirus Kunjin virus appear to occur in the rough endoplasmic reticulum and along the secretory pathway, respectively. J Virol 75:10787–10799 [CrossRef]
     [Google Scholar]
  35. Major M. E., Rehermann B., Feinstone S. M. 2001; Hepatitis C viruses. In Fields Virology , 4th edn. pp  1127–1161 Edited by Knipe D. M., Howley P. M. Philadelphia, PA: Lippincott Williams & Wilkins;
     [Google Scholar]
  36. Matsuura Y., Tani H., Suzuki K. 8 other authors 2001; Characterization of pseudotype VSV possessing HCV envelope proteins. Virology 286:263–275 [CrossRef]
     [Google Scholar]
  37. Michalak J.-P., Wychowski C., Choukhi A., Meunier J.-C., Ung S., Rice C. M., Dubuisson J. 1997; Characterization of truncated forms of hepatitis C virus glycoproteins. J Gen Virol 78:2299–2306
     [Google Scholar]
  38. Nakabayashi H., Taketa K., Miyano K., Yamane T., Sato J. 1982; Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res 42:3858–3863
     [Google Scholar]
  39. Nydegger S., Foti M., Derdowski A., Spearman P., Thali M. 2003; HIV-1 egress is gated through late endosomal membranes. Traffic 4:902–910 [CrossRef]
     [Google Scholar]
  40. Op De Beeck A., Montserret R., Duvet S., Cocquerel L., Cacan R., Barberot B., Le Maire M., Penin F., Dubuisson J. 2000; The transmembrane domains of hepatitis C virus envelope glycoproteins E1 and E2 play a major role in heterodimerization. J Biol Chem 275:31428–31437 [CrossRef]
     [Google Scholar]
  41. Op De Beeck A., Cocquerel L., Dubuisson J. 2001; Biogenesis of hepatitis C virus envelope glycoproteins. J Gen Virol 82:2589–2595
     [Google Scholar]
  42. Op De Beeck A., Voisset C., Bartosch B., Ciczora Y., Cocquerel L., Keck Z., Foung S., Cosset F.-L., Dubuisson J. 2004; Characterization of functional hepatitis C virus envelope glycoproteins. J Virol 78:2994–3002 [CrossRef]
     [Google Scholar]
  43. Orenstein J. M., Meltzer M. S., Phipps T., Gendelman H. E. 1988; Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony-stimulating factor-1-treated human monocytes: an ultrastructural study. J Virol 62:2578–2586
     [Google Scholar]
  44. Patel J., Patel A. H., McLauchlan J. 2001; The transmembrane domain of the hepatitis C virus E2 glycoprotein is required for correct folding of the E1 glycoprotein and native complex formation. Virology 279:58–68 [CrossRef]
     [Google Scholar]
  45. Pelchen-Matthews A., Kramer B., Marsh M. 2003; Infectious HIV-1 assembles in late endosomes in primary macrophages. J Cell Biol 162:443–455 [CrossRef]
     [Google Scholar]
  46. Penin F., Dubuisson J., Rey F. A., Moradpour D., Pawlotsky J.-M. 2004; Structural biology of hepatitis C virus. Hepatology 39:5–19 [CrossRef]
     [Google Scholar]
  47. Pornillos O., Garrus J. E., Sundquist W. I. 2002; Mechanisms of enveloped RNA virus budding. Trends Cell Biol 12:569–579 [CrossRef]
     [Google Scholar]
  48. Raposo G., Moore M., Innes D., Leijendekker R., Leigh-Brown A., Benaroch P., Geuze H. 2002; Human macrophages accumulate HIV-1 particles in MHC II compartments. Traffic 3:718–729 [CrossRef]
     [Google Scholar]
  49. Robertson B., Myers G., Howard C. 14 other authors 1998; Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. Arch Virol 143:2493–2503 [CrossRef]
     [Google Scholar]
  50. Sandrin V., Muriaux D., Darlix J.-L., Cosset F.-L. 2004; Intracellular trafficking of Gag and Env proteins and their interactions modulate pseudotyping of retroviruses. J Virol 78:7153–7164 [CrossRef]
     [Google Scholar]
  51. Sherer N. M., Lehmann M. J., Jimenez-Soto L. F. 7 other authors 2003; Visualization of retroviral replication in living cells reveals budding into multivesicular bodies. Traffic 4:785–801 [CrossRef]
     [Google Scholar]
  52. Shimizu Y. K., Feinstone S. M., Kohara M., Purcell R. H., Yoshikura H. 1996; Hepatitis C virus: detection of intracellular virus particles by electron microscopy. Hepatology 23:205–209 [CrossRef]
     [Google Scholar]
  53. Takikawa S., Ishii K., Aizaki H., Suzuki T., Asakura H., Matsuura Y., Miyamura T. 2000; Cell fusion activity of hepatitis C virus envelope proteins. J Virol 74:5066–5074 [CrossRef]
     [Google Scholar]
  54. Wakita T., Pietschmann T., Kato T. 9 other authors 2005; Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11:791–796 [CrossRef]
     [Google Scholar]
  55. Zhong J., Gastaminza P., Cheng G. 7 other authors 2005; Robust hepatitis C virus infection in vitro . Proc Natl Acad Sci U S A 102:9294–9299 [CrossRef]
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.81428-0
Loading
Assembly of functional hepatitis C virus glycoproteins on infectious pseudoparticles occurs intracellularly and requires concomitant incorporation of E1 and E2 glycoproteins
J. Gen. Virol. 86, 3189 (2005); https://doi.org/10.1099/vir.0.81428-0
/content/journal/jgv/10.1099/vir.0.81428-0
/content/journal/jgv/10.1099/vir.0.81428-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error